PubRank
Search
About
PIE II: Pharmacological Intervention in the Elderly II
Clinical Trial ID NCT00123955
PubWeight™ 1.90
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00123955
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
N Engl J Med
1999
29.32
2
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.
JAMA
2002
4.06
3
Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism.
J Am Coll Cardiol
1991
3.30
4
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.
Am J Cardiol
2001
2.93
5
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.
Circulation
2000
2.15
6
Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction.
Hypertension
2012
1.04
7
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Am J Cardiol
2002
0.96
8
Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure.
Congest Heart Fail
2009
0.94
Next 100